Literature DB >> 20421352

Is lateral epicondylitis a new indication for botulinum toxin?

Rachelle Buchbinder1, Bethan L Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20421352      PMCID： PMC2871194          DOI： 10.1503/cmaj.100358

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study.

Authors:  Richard Placzek; Wolf Drescher; Georg Deuretzbacher; Axel Hempfing; A Ludwig Meiss
Journal:  J Bone Joint Surg Am       Date:  2007-02       Impact factor: 5.284

2.  Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial.

Authors:  Ramin Espandar; Pedram Heidari; Mohammad Reza Rasouli; Soheil Saadat; Mahmood Farzan; Mohsen Rostami; Shideh Yazdanian; S M Javad Mortazavi
Journal:  CMAJ       Date:  2010-04-26       Impact factor: 8.262

3.  Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial.

Authors:  Shiu Man Wong; Andrew C F Hui; Po-Yee Tong; Dawn W F Poon; Evelyn Yu; Lawrence K S Wong
Journal:  Ann Intern Med       Date:  2005-12-06       Impact factor: 25.391

4.  Interobserver reproducibility of the assessment of severity of complaints, grip strength, and pressure pain threshold in patients with lateral epicondylitis.

Authors:  Nynke Smidt; Daniëlle A van der Windt; Willem J Assendelft; Anneke J Mourits; Walter L Devillé; Andrea F de Winter; Lex M Bouter
Journal:  Arch Phys Med Rehabil       Date:  2002-08       Impact factor: 3.966

Review 5.  Treatment of lateral epicondylitis.

Authors:  Greg W Johnson; Kara Cadwallader; Scot B Scheffel; Ted D Epperly
Journal:  Am Fam Physician       Date:  2007-09-15       Impact factor: 3.292

6.  Treatment of lateral epicondylitis using skin-derived tenocyte-like cells.

Authors:  D Connell; A Datir; F Alyas; M Curtis
Journal:  Br J Sports Med       Date:  2009-02-17       Impact factor: 13.800

7.  Quantitative exposure-response relations between physical workload and prevalence of lateral epicondylitis in a working population.

Authors:  Z Joyce Fan; Barbara A Silverstein; Stephen Bao; Dave K Bonauto; Ninica L Howard; Peregrin O Spielholz; Caroline K Smith; Nayak L Polissar; Eira Viikari-Juntura
Journal:  Am J Ind Med       Date:  2009-06       Impact factor: 2.214

8.  Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis.

Authors:  J A Paoloni; G A C Murrell; R M Burch; R Y Ang
Journal:  Br J Sports Med       Date:  2008-10-29       Impact factor: 13.800

Review 9.  A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma.

Authors:  D Rabago; T M Best; A E Zgierska; E Zeisig; M Ryan; D Crane
Journal:  Br J Sports Med       Date:  2008-11-21       Impact factor: 13.800

10.  Lateral epicondylitis in general practice: course and prognostic indicators of outcome.

Authors:  Nynke Smidt; Martyn Lewis; Daniëlle A W M VAN DER Windt; Elaine M Hay; Lex M Bouter; Peter Croft
Journal:  J Rheumatol       Date:  2006-08-01       Impact factor: 4.666
View more
  2 in total

1.  Effects of platelet-rich plasma on lateral epicondylitis of the elbow: prospective randomized controlled trial.

Authors:  Evandro Pereira Palacio; Rafael Ramos Schiavetti; Maiara Kanematsu; Tiago Moreno Ikeda; Roberto Ryuiti Mizobuchi; José Antônio Galbiatti
Journal:  Rev Bras Ortop       Date:  2016-01-13

2.  Allogeneic platelet-derived growth factors local injection in treatment of tennis elbow: a prospective randomized controlled study.

Authors:  Mahmoud Ibrahim Kandil; Abdel-Salam Abdel-Aleem Ahmed; Rasha Shaker Eldesouky; Sherif Eltregy
Journal:  Int Orthop       Date:  2022-01-12       Impact factor: 3.479
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.